Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Kedudukan dalam Saham #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Harga Saham
$0.85814713
Disegerakkan terakhir: 2025-05-14
Modal Pasaran
$463.40M
Perubahan (1 hari)
-2.52%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Alliance Pharma plc (APH)

Kategori

EPS untuk Alliance Pharma plc (APH)
EPS setakat December 2024 TTM: $-0.03
Menurut laporan kewangan terkini dan harga saham Alliance Pharma plc, EPS semasa syarikat (TTM) adalah $-0.03. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.08 penurunan berbanding EPS tahun 2022 iaitu $0.00.
Sejarah EPS untuk Alliance Pharma plc dari 2001 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.03 -16.67%
2024 $-0.03 -67.95%
2023 $-0.08 -3,814.29%
2022 0.00 -88.65%
2021 $0.02 -12.32%
2020 $0.02 -66.88%
2019 $0.06 35.53%
2018 $0.05 -42.96%
2017 $0.08 73.47%
2016 $0.05 -30.66%
2015 $0.07 38.66%
2014 $0.05 -21.96%
2013 $0.06 8.02%
2012 $0.06 4.27%
2011 $0.06 -8.77%
2010 $0.06 60.42%
2009 $0.04 69.91%
2008 $0.02 -157.22%
2007 $-0.04 -726.98%
2006 $0.01 -18.18%
2005 $0.01 -116.96%
2004 $-0.05 109.22%
2002 $-0.02 -401.39%
2001 $0.01 0.00%
EPS untuk syarikat atau pesaing yang serupa